SCM
NXTC icon

Squadron Capital Management’s NextCure NXTC Stock Holding History

Squadron Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
64,464
-200,536
-76% -$1.48M 0.03% 43
2026
Q1 		$2.83M Buy
265,000
+28,034
+12% +$342K 1.04% 27
2025
Q4 		$3.36M Buy
+236,966
New +$2.46M 1.43% 23

Other funds holding NXTC

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Squadron Capital Management's NXTC Position: Q2 2026 in Review

Squadron Capital Management reduced its NextCure (NXTC) stake by 76% in Q2 2026, selling an estimated $1.48M and leaving 64,464 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #43.

Squadron Capital Management first reported a position in NXTC in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.36M in Q4 2025. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Squadron Capital Management held 64,464 shares of NextCure worth $103K as of Q2 2026.
  • Squadron Capital Management sold 200,536 NextCure shares in Q2 2026, an estimated $1.48M.
  • NextCure made up 0.03% of Squadron Capital Management's portfolio in Q2 2026, its #43 holding.
  • Squadron Capital Management first reported a position in NextCure in Q4 2025 and has held it in 3 quarters since.
  • Squadron Capital Management's NextCure position peaked at $3.36M in Q4 2025.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Squadron Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.